[
  {
    "title": "天士力(600535.SH)：芪参益气滴丸新增糖尿病肾脏疾病适应症获得临床批准",
    "href": "http://stock.jrj.com.cn/2022/12/16153837218064.shtml",
    "datetime": "2022-12-16 15:38:55",
    "code": "600535"
  },
  {
    "title": "A股异动 | 天士力(600535.SH)涨停创7个月新高 近2个月股价已反弹超37%",
    "href": "http://stock.jrj.com.cn/2022/11/17161537146768.shtml",
    "datetime": "2022-11-17 16:15:45",
    "code": "600535"
  },
  {
    "title": "上市公司“痴迷”炒股，天士力亏12亿，云南白药亏7.5亿，还有亏38亿的",
    "href": "http://stock.jrj.com.cn/2022/11/02181637107288.shtml",
    "datetime": "2022-11-02 18:16:10",
    "code": "600535"
  },
  {
    "title": "【龙虎榜】天士力10月27日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/10/27180537090371.shtml",
    "datetime": "2022-10-27 18:05:14",
    "code": "600535"
  },
  {
    "title": "天士力2022年前三季度亏损3.34亿同比由盈转亏 金融资产公允价值下降",
    "href": "http://stock.jrj.com.cn/2022/10/25185037082656.shtml",
    "datetime": "2022-10-25 18:50:42",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：前三季度扣非净利润7.69亿元，同比减少17.62%",
    "href": "http://stock.jrj.com.cn/2022/10/25153537081507.shtml",
    "datetime": "2022-10-25 15:35:49",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：九味化斑丸治疗斑块型银屑病的临床试验获批",
    "href": "http://stock.jrj.com.cn/2022/09/29193037031941.shtml",
    "datetime": "2022-09-29 19:30:30",
    "code": "600535"
  },
  {
    "title": "天士力：控股子公司获得B1344注射液临床试验批准通知书",
    "href": "http://stock.jrj.com.cn/2022/09/19154337004740.shtml",
    "datetime": "2022-09-19 15:43:53",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：天士力生物培重组人成纤维细胞生长因子21注射液获批临床试验",
    "href": "http://stock.jrj.com.cn/2022/09/19153837004727.shtml",
    "datetime": "2022-09-19 15:38:48",
    "code": "600535"
  },
  {
    "title": "天士力：注射用硼替佐米获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/09/06154436976854.shtml",
    "datetime": "2022-09-06 15:44:36",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：注射用硼替佐米获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/09/06153536976837.shtml",
    "datetime": "2022-09-06 15:35:39",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：江苏帝益药品赖诺普利氢氯噻嗪片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/09/05171236974151.shtml",
    "datetime": "2022-09-05 17:12:34",
    "code": "600535"
  },
  {
    "title": "天士力：全资子公司药品赖诺普利氢氯噻嗪片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/09/05171036974121.shtml",
    "datetime": "2022-09-05 17:10:37",
    "code": "600535"
  },
  {
    "title": "天士力：终止分拆所属子公司天士力生物上市",
    "href": "http://stock.jrj.com.cn/2022/08/19172336916669.shtml",
    "datetime": "2022-08-19 17:23:01",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：拟购买辽宁参茸保健品公司部分工业房地产及其内部不可拆卸设备",
    "href": "http://stock.jrj.com.cn/2022/08/19160836916179.shtml",
    "datetime": "2022-08-19 16:08:04",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：终止分拆天士力生物至上交所科创板上市",
    "href": "http://stock.jrj.com.cn/2022/08/19160536916187.shtml",
    "datetime": "2022-08-19 16:05:22",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)上半年净亏损4.08亿元 同比转亏",
    "href": "http://stock.jrj.com.cn/2022/08/19155636916145.shtml",
    "datetime": "2022-08-19 15:56:04",
    "code": "600535"
  },
  {
    "title": "天士力：终止分拆天士力生物上市",
    "href": "http://stock.jrj.com.cn/2022/08/19155236916101.shtml",
    "datetime": "2022-08-19 15:52:54",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：B1962注射液获批开展晚期实体瘤临床试验",
    "href": "http://stock.jrj.com.cn/2022/08/04182536870975.shtml",
    "datetime": "2022-08-04 18:25:26",
    "code": "600535"
  },
  {
    "title": "天士力2022年上半年预计亏损3.59亿-4.21亿同比由盈转亏 歌礼股权处置收益减少",
    "href": "http://stock.jrj.com.cn/2022/07/14223136813239.shtml",
    "datetime": "2022-07-14 22:31:57",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)2021年度权益分派10派3.3元 股权登记日为6月17日",
    "href": "http://stock.jrj.com.cn/2022/06/13160136724167.shtml",
    "datetime": "2022-06-13 16:01:55",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：已完成股票回购方案、累计回购821.94万股",
    "href": "http://stock.jrj.com.cn/2022/05/29170336687369.shtml",
    "datetime": "2022-05-29 17:03:07",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：控股子公司撤回注射用重组人尿激酶原增加急性缺血性脑卒中新适应症注册申请",
    "href": "http://stock.jrj.com.cn/2022/05/13160836646519.shtml",
    "datetime": "2022-05-13 16:08:59",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)截至4月底已累计回购821.94万股",
    "href": "http://stock.jrj.com.cn/2022/05/06194636582564.shtml",
    "datetime": "2022-05-06 19:46:32",
    "code": "600535"
  },
  {
    "title": "【龙虎榜】天士力4月28日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/04/28181336494059.shtml",
    "datetime": "2022-04-28 18:13:42",
    "code": "600535"
  },
  {
    "title": "天士力2022年第一季度亏损5.57亿同比由盈转亏 公允价值变动收益下降",
    "href": "http://stock.jrj.com.cn/2022/04/26101336472946.shtml",
    "datetime": "2022-04-26 10:13:00",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)一季度净亏损5.57亿元",
    "href": "http://stock.jrj.com.cn/2022/04/25154436463288.shtml",
    "datetime": "2022-04-25 15:44:09",
    "code": "600535"
  },
  {
    "title": "天士力2021年净利23.59亿同比增长109.51% 董事长闫凯境薪酬280.62万",
    "href": "http://stock.jrj.com.cn/2022/03/30203136205103.shtml",
    "datetime": "2022-03-30 20:31:52",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：2021年净利增109.51%至23.59亿元 拟10派3.3元",
    "href": "http://stock.jrj.com.cn/2022/03/30162236196963.shtml",
    "datetime": "2022-03-30 16:22:57",
    "code": "600535"
  },
  {
    "title": "天士力：藿香正气滴丸等产品被列入新冠肺炎诊疗方案（试行第九版）",
    "href": "http://stock.jrj.com.cn/2022/03/18154634845063.shtml",
    "datetime": "2022-03-18 15:46:00",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：藿香正气滴丸等产品列入《新型冠状病毒肺炎诊疗方案(试行第九版)》",
    "href": "http://stock.jrj.com.cn/2022/03/18153634845015.shtml",
    "datetime": "2022-03-18 15:36:01",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：天士力控股集团解质1.03亿股",
    "href": "http://stock.jrj.com.cn/2022/03/15160434829159.shtml",
    "datetime": "2022-03-15 16:04:29",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：拟以可转债方式对力成药业投资8000万元",
    "href": "http://stock.jrj.com.cn/2022/03/11171334814433.shtml",
    "datetime": "2022-03-11 17:13:58",
    "code": "600535"
  },
  {
    "title": "天士力：已回购393.76万股 支付总金额约5473.51万元",
    "href": "http://stock.jrj.com.cn/2022/02/07174034302375.shtml",
    "datetime": "2022-02-07 17:40:00",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：截至1月底已累计回购393.76万股",
    "href": "http://stock.jrj.com.cn/2022/02/07161134301772.shtml",
    "datetime": "2022-02-07 16:11:59",
    "code": "600535"
  },
  {
    "title": "天士力2021年预计净利23.8亿-24.7亿同比增长112%-119% 处置I-MAB股权获得收益",
    "href": "http://stock.jrj.com.cn/2022/01/28193134246155.shtml",
    "datetime": "2022-01-28 19:31:56",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：2021年度净利预增112%-119%",
    "href": "http://stock.jrj.com.cn/2022/01/28160934242911.shtml",
    "datetime": "2022-01-28 16:09:54",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：B1344注射液获得美国FDA临床试验许可",
    "href": "http://stock.jrj.com.cn/2022/01/25160934210106.shtml",
    "datetime": "2022-01-25 16:09:18",
    "code": "600535"
  },
  {
    "title": "国台研究院成立 构建国台中国新名酒最强大脑",
    "href": "http://stock.jrj.com.cn/2022/01/10120334140499.shtml",
    "datetime": "2022-01-10 12:03:57",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：子公司就STRO-002相关权益与Sutro签署许可协议",
    "href": "http://stock.jrj.com.cn/2021/12/24172134058578.shtml",
    "datetime": "2021-12-24 17:21:21",
    "code": "600535"
  },
  {
    "title": "天士力：子公司盐酸美金刚缓释胶囊获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/12/20160134034578.shtml",
    "datetime": "2021-12-20 16:01:47",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：子公司盐酸美金刚缓释胶囊获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/12/20153434034413.shtml",
    "datetime": "2021-12-20 15:34:57",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：子公司拟协议转让所持IMAB的0.28%非流通普通股予华泰资本",
    "href": "http://stock.jrj.com.cn/2021/12/10181333995426.shtml",
    "datetime": "2021-12-10 18:13:56",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)截至11月底已累计回购261.52万股",
    "href": "http://stock.jrj.com.cn/2021/12/02153233955327.shtml",
    "datetime": "2021-12-02 15:32:49",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：坤心宁颗粒获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/11/29161733938129.shtml",
    "datetime": "2021-11-29 16:17:39",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：子公司完成协议转让I-MAB 0.34%的非流通普通股",
    "href": "http://stock.jrj.com.cn/2021/11/19181233881126.shtml",
    "datetime": "2021-11-19 18:12:27",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：控股股东解除质押4580万股",
    "href": "http://stock.jrj.com.cn/2021/11/12161533841165.shtml",
    "datetime": "2021-11-12 16:15:45",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：控股股东解除质押3053万股",
    "href": "http://stock.jrj.com.cn/2021/11/05161133817021.shtml",
    "datetime": "2021-11-05 16:11:28",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：控股股东解除质押5815万股",
    "href": "http://stock.jrj.com.cn/2021/11/01162333798043.shtml",
    "datetime": "2021-11-01 16:23:50",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：累计回购0.1163%股份",
    "href": "http://stock.jrj.com.cn/2021/11/01153833797702.shtml",
    "datetime": "2021-11-01 15:38:28",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：第三季度净利润升15.67%至4.79亿元",
    "href": "http://stock.jrj.com.cn/2021/10/26164233754917.shtml",
    "datetime": "2021-10-26 16:42:20",
    "code": "600535"
  },
  {
    "title": "中药、生物药持续快增，天士力前三季净利润劲升35%",
    "href": "http://stock.jrj.com.cn/2021/10/26160933754653.shtml",
    "datetime": "2021-10-26 16:09:21",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：子公司苯扎贝特缓释片获批上市",
    "href": "http://stock.jrj.com.cn/2021/10/21162633727371.shtml",
    "datetime": "2021-10-21 16:26:24",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：子公司注射用替莫唑胺获批上市",
    "href": "http://stock.jrj.com.cn/2021/10/21153633727012.shtml",
    "datetime": "2021-10-21 15:36:20",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：收到复方丹参滴丸的药品补充申请批准通知书",
    "href": "http://stock.jrj.com.cn/2021/10/12155233679310.shtml",
    "datetime": "2021-10-12 15:52:35",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)截至9月底已累计回购155.92万股",
    "href": "http://stock.jrj.com.cn/2021/10/11153533672928.shtml",
    "datetime": "2021-10-11 15:35:30",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：控股股东解质及质押4400万股",
    "href": "http://stock.jrj.com.cn/2021/09/24153933509997.shtml",
    "datetime": "2021-09-24 15:39:14",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：逍遥片获得荷兰药物评审委员会注册批准",
    "href": "http://stock.jrj.com.cn/2021/09/08154033404126.shtml",
    "datetime": "2021-09-08 15:40:51",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)截至8月底已累计回购115.09万股",
    "href": "http://stock.jrj.com.cn/2021/09/02153933374233.shtml",
    "datetime": "2021-09-02 15:39:32",
    "code": "600535"
  },
  {
    "title": "天士力半年报：上半年净利润10.02亿元 同比增长46%",
    "href": "http://stock.jrj.com.cn/2021/08/25170333317075.shtml",
    "datetime": "2021-08-25 17:03:04",
    "code": "600535"
  },
  {
    "title": "天士力2021年半年度净利10.02亿元 同比净利增加46.10%",
    "href": "http://stock.jrj.com.cn/2021/08/25163033316720.shtml",
    "datetime": "2021-08-25 16:30:00",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)半年度净利润10.02亿元 同比增长46.10%",
    "href": "http://stock.jrj.com.cn/2021/08/25154233316348.shtml",
    "datetime": "2021-08-25 15:42:54",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：控股股东解押2200万股及质押的3400万股展期",
    "href": "http://stock.jrj.com.cn/2021/08/02160733189295.shtml",
    "datetime": "2021-08-02 16:07:01",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)截至7月底已累计回购84.19万股",
    "href": "http://stock.jrj.com.cn/2021/08/02160433189283.shtml",
    "datetime": "2021-08-02 16:04:41",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：JS1-1-01片用于中重度抑郁症治疗获美国FDA临床试验批准",
    "href": "http://stock.jrj.com.cn/2021/08/02160333189281.shtml",
    "datetime": "2021-08-02 16:03:02",
    "code": "600535"
  },
  {
    "title": "天士力主打产品销量下滑中药业务萎靡 股价锐降六成员工持股计划浮亏近半",
    "href": "http://stock.jrj.com.cn/2021/08/02074933201625.shtml",
    "datetime": "2021-08-02 07:49:40",
    "code": "600535"
  },
  {
    "title": "天士力主打产品销量下滑中药业务萎靡 股价锐降六成员工持股计划浮亏近半",
    "href": "http://stock.jrj.com.cn/2021/08/02074933189466.shtml",
    "datetime": "2021-08-02 07:49:40",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：开展T89预防及治疗急性高原反应Ⅲ期临床试验",
    "href": "http://stock.jrj.com.cn/2021/07/22165833135683.shtml",
    "datetime": "2021-07-22 16:58:56",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：控股股东的一致行动人合计解质2542.5万股",
    "href": "http://stock.jrj.com.cn/2021/07/02155133033685.shtml",
    "datetime": "2021-07-02 15:51:12",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：截至6月底累计耗资1007.24万元回购73.93万股",
    "href": "http://stock.jrj.com.cn/2021/07/01154333027535.shtml",
    "datetime": "2021-07-01 15:43:35",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)6月25日首次回购45.63万股",
    "href": "http://stock.jrj.com.cn/2021/06/25153232996228.shtml",
    "datetime": "2021-06-25 15:32:59",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：2020年度权益分派10派3.3元 股权登记日6月23日",
    "href": "http://stock.jrj.com.cn/2021/06/17184032948830.shtml",
    "datetime": "2021-06-17 18:40:28",
    "code": "600535"
  },
  {
    "title": "天士力：控股子公司协议转让I-MAB部分非流通普通股",
    "href": "http://stock.jrj.com.cn/2021/06/12060532914900.shtml",
    "datetime": "2021-06-12 06:05:46",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：子公司协议转让I-MAB部分非流通普通股 实现投资收益约2.2亿元",
    "href": "http://stock.jrj.com.cn/2021/06/11154432911345.shtml",
    "datetime": "2021-06-11 15:44:04",
    "code": "600535"
  },
  {
    "title": "天士力将花不超2亿元回购公司股份 用于注销以减少注册资本",
    "href": "http://stock.jrj.com.cn/2021/06/02210032865483.shtml",
    "datetime": "2021-06-02 21:00:33",
    "code": "600535"
  },
  {
    "title": "天士力4年23亿投研发 拟分拆生物板块转战科创板募资24亿",
    "href": "http://stock.jrj.com.cn/ipo/2021/05/31081132979014.shtml",
    "datetime": "2021-05-31 08:11:08",
    "code": "600535"
  },
  {
    "title": "天士力4年23亿投研发 拟分拆生物板块转战科创板募资24亿",
    "href": "http://stock.jrj.com.cn/ipo/2021/05/31081132909108.shtml",
    "datetime": "2021-05-31 08:11:08",
    "code": "600535"
  },
  {
    "title": "天士力：目前公司已取得国家药品审批中心关于同意在中国开展国际多中心药物临床研究（MRCT）的批准意见",
    "href": "http://stock.jrj.com.cn/2021/05/10122532728156.shtml",
    "datetime": "2021-05-10 12:25:28",
    "code": "600535"
  },
  {
    "title": "天士力：治疗用乙型肝炎腺病毒注射液T101快速推进II期临床试验 已完成所有受试者入组",
    "href": "http://stock.jrj.com.cn/2021/05/10122132728126.shtml",
    "datetime": "2021-05-10 12:21:00",
    "code": "600535"
  },
  {
    "title": "天士力：普佑克急性缺血性脑卒中适应症为国内注册申请",
    "href": "http://stock.jrj.com.cn/2021/05/10121532728074.shtml",
    "datetime": "2021-05-10 12:15:04",
    "code": "600535"
  },
  {
    "title": "天士力：公司前两年持续回购股份均将用于员工股权激励",
    "href": "http://stock.jrj.com.cn/2021/05/10121132728050.shtml",
    "datetime": "2021-05-10 12:11:58",
    "code": "600535"
  },
  {
    "title": "天士力：公司于2021年1月底购买云南麻叶生物科技有限公司及所属公司股权并增资后持有该公司51%的股权",
    "href": "http://stock.jrj.com.cn/2021/05/10121032728045.shtml",
    "datetime": "2021-05-10 12:10:58",
    "code": "600535"
  },
  {
    "title": "天士力：天士力生物已与中信证券股份有限公司就申请科创板上市签订了上市辅导协议",
    "href": "http://stock.jrj.com.cn/2021/05/10121032728044.shtml",
    "datetime": "2021-05-10 12:10:01",
    "code": "600535"
  },
  {
    "title": "天士力2021年第一季度净利3.23亿增长9.53% 营业成本下降",
    "href": "http://stock.jrj.com.cn/2021/04/24200232435738.shtml",
    "datetime": "2021-04-24 20:02:53",
    "code": "600535"
  },
  {
    "title": "天士力2020年净利11.26亿增长12.43% 董事长闫凯境薪酬283.14万",
    "href": "http://stock.jrj.com.cn/2021/04/24173932435397.shtml",
    "datetime": "2021-04-24 17:39:53",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)拟以1亿-2亿元回购公司股份",
    "href": "http://stock.jrj.com.cn/2021/04/23182232431187.shtml",
    "datetime": "2021-04-23 18:22:53",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)2020年度净利润升12.43%至11.26亿元 拟10派3.3元",
    "href": "http://stock.jrj.com.cn/2021/04/23182032431172.shtml",
    "datetime": "2021-04-23 18:20:23",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)一季度净利润升9.53%至3.23亿元",
    "href": "http://stock.jrj.com.cn/2021/04/23181532431144.shtml",
    "datetime": "2021-04-23 18:15:40",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：天士力控股集团解质押3500万股及质押1.03亿股",
    "href": "http://stock.jrj.com.cn/2021/03/05154432078294.shtml",
    "datetime": "2021-03-05 15:44:34",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：氯氮平片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/02/18153931986166.shtml",
    "datetime": "2021-02-18 15:39:37",
    "code": "600535"
  },
  {
    "title": "天士力生物启动上市辅导：曾两度撤回上市申请",
    "href": "http://stock.jrj.com.cn/2021/02/02105931835352.shtml",
    "datetime": "2021-02-02 10:59:22",
    "code": "600535"
  },
  {
    "title": "天士力生物重启IPO 已完成辅导备案",
    "href": "http://stock.jrj.com.cn/ipo/2021/01/30085431813769.shtml",
    "datetime": "2021-01-30 08:54:50",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：吉非替尼片获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/01/08182031656639.shtml",
    "datetime": "2021-01-08 18:20:23",
    "code": "600535"
  },
  {
    "title": "米诺膦酸片首仿上市，天士力化药研发屡结硕果！",
    "href": "http://stock.jrj.com.cn/2021/01/07161931648284.shtml",
    "datetime": "2021-01-07 16:19:58",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)截至12月底累计斥资9476.36万元回购496.58万股",
    "href": "http://stock.jrj.com.cn/2021/01/05160031634611.shtml",
    "datetime": "2021-01-05 16:00:34",
    "code": "600535"
  },
  {
    "title": "天士力：独家产品芍麻止痉颗粒首次被纳入《国家医保目录》",
    "href": "http://stock.jrj.com.cn/2020/12/28171031586840.shtml",
    "datetime": "2020-12-28 17:10:39",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：独家产品芍麻止痉颗粒首次纳入国家医保目录",
    "href": "http://stock.jrj.com.cn/2020/12/28170931586836.shtml",
    "datetime": "2020-12-28 17:09:17",
    "code": "600535"
  },
  {
    "title": "天士力控股股东天士力控股集团质押6000万股 用于补充流动性及偿还借款",
    "href": "http://stock.jrj.com.cn/2020/12/11193831466723.shtml",
    "datetime": "2020-12-11 19:38:28",
    "code": "600535"
  },
  {
    "title": "天士力2名股东合计质押2542.5万股 用于天士力控股集团偿还借款",
    "href": "http://stock.jrj.com.cn/2020/12/08192831442233.shtml",
    "datetime": "2020-12-08 19:28:25",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)：控股股东一致行动人质押2542.5万股",
    "href": "http://stock.jrj.com.cn/2020/12/08170831441007.shtml",
    "datetime": "2020-12-08 17:08:18",
    "code": "600535"
  },
  {
    "title": "天士力：中药配方颗粒业务属于上市公司业务",
    "href": "http://stock.jrj.com.cn/2020/11/23145831333619.shtml",
    "datetime": "2020-11-23 14:58:26",
    "code": "600535"
  },
  {
    "title": "民族品牌指数跌0.38% 汽车类成分股表现活跃",
    "href": "http://stock.jrj.com.cn/2020/11/18021231303083.shtml",
    "datetime": "2020-11-18 02:12:12",
    "code": "600535"
  },
  {
    "title": "天士力控股股东天士力控股集团质押7633万股 用于偿还借款",
    "href": "http://stock.jrj.com.cn/2020/11/13211431277749.shtml",
    "datetime": "2020-11-13 21:14:34",
    "code": "600535"
  },
  {
    "title": "天士力前三季度净利11亿下滑2.84% 对外捐赠增加",
    "href": "http://stock.jrj.com.cn/2020/10/28184831151874.shtml",
    "datetime": "2020-10-28 18:48:51",
    "code": "600535"
  },
  {
    "title": "天士力分拆子公司天士生物赴科创板上市 拟募资超20亿元主要用于新药研发| 产业新股",
    "href": "http://stock.jrj.com.cn/2020/10/20181131093446.shtml",
    "datetime": "2020-10-20 18:11:46",
    "code": "600535"
  },
  {
    "title": "[陇神戎发]【集团新闻】天士力控股集团董事局主席闫希军一行来甘肃考察中医药产业发展",
    "href": "http://stock.jrj.com.cn/2020/10/20000031094063.shtml",
    "datetime": "2020-10-20 00:00:00",
    "code": "600535"
  },
  {
    "title": "[陇神戎发]天士力控股集团董事局主席闫希军一行赴陇神戎发参观考察",
    "href": "http://stock.jrj.com.cn/2020/10/19000031083854.shtml",
    "datetime": "2020-10-19 00:00:00",
    "code": "600535"
  },
  {
    "title": "天士力：天士力生物科创板上市申请已获上海证券交易所受理",
    "href": "http://stock.jrj.com.cn/2020/10/14082631048656.shtml",
    "datetime": "2020-10-14 08:26:59",
    "code": "600535"
  },
  {
    "title": "天士力(600535.SH)截至9月底累计斥资9427.99万元回购493.38万股",
    "href": "http://stock.jrj.com.cn/2020/10/09171331011072.shtml",
    "datetime": "2020-10-09 17:13:35",
    "code": "600535"
  },
  {
    "title": "天士生物：天士力子公司申请科创板上市 2019年营收承压",
    "href": "http://stock.jrj.com.cn/kcb/2020/09/22073130807024.shtml",
    "datetime": "2020-09-22 07:31:30",
    "code": "600535"
  },
  {
    "title": "天士力：天境生物、永泰生物两家公司为天士力投资项目",
    "href": "http://stock.jrj.com.cn/2020/09/16120230761407.shtml",
    "datetime": "2020-09-16 12:02:31",
    "code": "600535"
  },
  {
    "title": "天士力送“子”赶考 科创板两公司IPO申请获受理",
    "href": "http://stock.jrj.com.cn/kcb/2020/09/04042830671748.shtml",
    "datetime": "2020-09-04 04:28:13",
    "code": "600535"
  },
  {
    "title": "天士力：控股子公司天士力生物科创板上市申请获上交所受理",
    "href": "http://stock.jrj.com.cn/2020/09/03155330668679.shtml",
    "datetime": "2020-09-03 15:53:57",
    "code": "600535"
  },
  {
    "title": "天士力2020年上半年净利6.86亿下滑23.65% 医药工业收入下降",
    "href": "http://stock.jrj.com.cn/2020/08/25230430588593.shtml",
    "datetime": "2020-08-25 23:04:08",
    "code": "600535"
  },
  {
    "title": "天士力生物创新药战略转型逐渐兑现 上半年经营性现金流同比增长49%",
    "href": "http://stock.jrj.com.cn/2020/08/25220930588236.shtml",
    "datetime": "2020-08-25 22:09:00",
    "code": "600535"
  },
  {
    "title": "天士力二季度业绩明显改善 分拆天士力生物科创板上市取得积极进展",
    "href": "http://stock.jrj.com.cn/2020/08/25170830586647.shtml",
    "datetime": "2020-08-25 17:08:38",
    "code": "600535"
  },
  {
    "title": "天士力：抑郁症化学药品1类新药获批 将于近期开展临床试验",
    "href": "http://stock.jrj.com.cn/2020/08/05174030434022.shtml",
    "datetime": "2020-08-05 17:40:09",
    "code": "600535"
  },
  {
    "title": "天士力：治疗抑郁症新药获得药物临床试验批准通知书",
    "href": "http://stock.jrj.com.cn/2020/08/05162530432728.shtml",
    "datetime": "2020-08-05 16:25:34",
    "code": "600535"
  },
  {
    "title": "民族品牌指数涨0.38%天士力舒必利片获批",
    "href": "http://stock.jrj.com.cn/2020/07/21072730300766.shtml",
    "datetime": "2020-07-21 07:27:37",
    "code": "600535"
  },
  {
    "title": "天士力舒必利片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/07/20190930295032.shtml",
    "datetime": "2020-07-20 19:09:19",
    "code": "600535"
  },
  {
    "title": "天士力舒必利片业内首家过评 化药集群显现未来放量可期",
    "href": "http://stock.jrj.com.cn/2020/07/20180130294232.shtml",
    "datetime": "2020-07-20 18:01:45",
    "code": "600535"
  },
  {
    "title": "天士力：舒必利片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/07/20153930293006.shtml",
    "datetime": "2020-07-20 15:39:43",
    "code": "600535"
  },
  {
    "title": "快讯：天士力急速拉升6.84% 主力资金净流出3630.27万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/07/01094830108035.shtml",
    "datetime": "2020-07-01 09:48:11",
    "code": "600535"
  },
  {
    "title": "快讯：天士力急速拉升6.84% 主力资金净流出4000.07万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/07/01094830108034.shtml",
    "datetime": "2020-07-01 09:48:01",
    "code": "600535"
  },
  {
    "title": "快讯：天士力急速拉升7.16% 主力资金净流入2817.13万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/06/30100930094589.shtml",
    "datetime": "2020-06-30 10:09:00",
    "code": "600535"
  },
  {
    "title": "快讯：天士力急速拉升7.16% 主力资金净流入2817.13万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/06/30100930094590.shtml",
    "datetime": "2020-06-30 10:09:00",
    "code": "600535"
  },
  {
    "title": "剥离营销业务 天士力押宝医药工业",
    "href": "http://stock.jrj.com.cn/2020/06/18021729952788.shtml",
    "datetime": "2020-06-18 02:17:07",
    "code": "600535"
  },
  {
    "title": "重药控股重组上市连续三年业绩超预期 15亿并购天士力填补医药商业布局空白",
    "href": "http://stock.jrj.com.cn/2020/06/17075429954929.shtml",
    "datetime": "2020-06-17 07:54:52",
    "code": "600535"
  },
  {
    "title": "天士力：拟向重庆医药出售天士营销99.9448%股权",
    "href": "http://stock.jrj.com.cn/2020/06/14173329917631.shtml",
    "datetime": "2020-06-14 17:33:02",
    "code": "600535"
  },
  {
    "title": "天士力：关于召开2020年第一次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/06/13002029912084.shtml",
    "datetime": "2020-06-13 00:20:01",
    "code": "600535"
  },
  {
    "title": "天士力：第七届董事会第16次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/06/13002029912083.shtml",
    "datetime": "2020-06-13 00:20:01",
    "code": "600535"
  },
  {
    "title": "天士力：拟14.89亿元出售子公司股权 退出医药分销配送业务",
    "href": "http://stock.jrj.com.cn/2020/06/12221329911589.shtml",
    "datetime": "2020-06-12 22:13:00",
    "code": "600535"
  },
  {
    "title": "天士力：拟分拆子公司天士力生物到科创板上市",
    "href": "http://stock.jrj.com.cn/2020/06/12214529911455.shtml",
    "datetime": "2020-06-12 21:45:00",
    "code": "600535"
  },
  {
    "title": "天士力生物提交科创板上市辅导备案：此前启动香港IPO但估值未达预期",
    "href": "http://stock.jrj.com.cn/kcb/2020/06/12084629905333.shtml",
    "datetime": "2020-06-12 08:46:35",
    "code": "600535"
  },
  {
    "title": "被瑞幸事件吓退还是A股韭菜好割？天士力生物弃海外回科创板疑团",
    "href": "http://stock.jrj.com.cn/kcb/2020/06/09080329877486.shtml",
    "datetime": "2020-06-09 08:03:16",
    "code": "600535"
  },
  {
    "title": "天士力：2019年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2020/06/05232029856037.shtml",
    "datetime": "2020-06-05 23:20:04",
    "code": "600535"
  },
  {
    "title": "医药工业板块难提振 天士力2019年六大主要产品过半销售量下滑",
    "href": "http://stock.jrj.com.cn/hotstock/2020/05/20130329720901.shtml",
    "datetime": "2020-05-20 13:03:40",
    "code": "600535"
  },
  {
    "title": "天士力：2019年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2020/05/19073029708271.shtml",
    "datetime": "2020-05-19 07:30:01",
    "code": "600535"
  },
  {
    "title": "天士力引进治疗胰腺癌及黑色素瘤的溶瘤病毒产品",
    "href": "http://stock.jrj.com.cn/2020/05/11214629644049.shtml",
    "datetime": "2020-05-11 21:46:48",
    "code": "600535"
  },
  {
    "title": "不再舍近求远去境外上市啦！天士力拟分拆子公司冲刺科创板",
    "href": "http://stock.jrj.com.cn/2020/05/08074029615460.shtml",
    "datetime": "2020-05-08 07:40:39",
    "code": "600535"
  },
  {
    "title": "天士力拟分拆子公司天士力生物至科创板上市",
    "href": "http://stock.jrj.com.cn/2020/05/07221529612897.shtml",
    "datetime": "2020-05-07 22:15:00",
    "code": "600535"
  },
  {
    "title": "天士力：控股子公司获临床试验通知书",
    "href": "http://stock.jrj.com.cn/2020/05/07171929610680.shtml",
    "datetime": "2020-05-07 17:19:23",
    "code": "600535"
  },
  {
    "title": "天士力将花不超2亿元回购公司股份 用于股权激励",
    "href": "http://stock.jrj.com.cn/2020/05/04144629533266.shtml",
    "datetime": "2020-05-04 14:46:46",
    "code": "600535"
  },
  {
    "title": "天士力2019年净利10.01亿下滑35.19% 中药材大宗家种品种价格小浮下滑",
    "href": "http://stock.jrj.com.cn/2020/04/26105929376708.shtml",
    "datetime": "2020-04-26 10:59:10",
    "code": "600535"
  },
  {
    "title": "天士力将花不超2亿元回购公司股份 用于股权激励",
    "href": "http://stock.jrj.com.cn/2020/04/26102429376501.shtml",
    "datetime": "2020-04-26 10:24:34",
    "code": "600535"
  },
  {
    "title": "天士力第一季度盈利2.95亿同比减少34.21% 销售回款均下降",
    "href": "http://stock.jrj.com.cn/2020/04/25131629374137.shtml",
    "datetime": "2020-04-25 13:16:59",
    "code": "600535"
  },
  {
    "title": "天士力：关于召开2019年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/04/25051029371710.shtml",
    "datetime": "2020-04-25 05:10:03",
    "code": "600535"
  },
  {
    "title": "天士力：2020年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/04/25051029371708.shtml",
    "datetime": "2020-04-25 05:10:02",
    "code": "600535"
  },
  {
    "title": "天士力：2019年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/04/25051029371707.shtml",
    "datetime": "2020-04-25 05:10:02",
    "code": "600535"
  },
  {
    "title": "天士力：第七届董事会第14次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/04/25051029371709.shtml",
    "datetime": "2020-04-25 05:10:02",
    "code": "600535"
  },
  {
    "title": "天士力：2019年实现营收190亿元 拟1亿元至2亿元回购股份",
    "href": "http://stock.jrj.com.cn/2020/04/24221529370036.shtml",
    "datetime": "2020-04-24 22:15:00",
    "code": "600535"
  },
  {
    "title": "天士力参与中澳业界携手研讨抗击疫情最佳解决方案",
    "href": "http://stock.jrj.com.cn/2020/04/06204429215261.shtml",
    "datetime": "2020-04-06 20:44:52",
    "code": "600535"
  },
  {
    "title": "天士力：协办承办国际学术交流会 探讨新冠肺炎最佳解决方案",
    "href": "http://stock.jrj.com.cn/2020/04/06123329213986.shtml",
    "datetime": "2020-04-06 12:33:00",
    "code": "600535"
  },
  {
    "title": "天士力：收到养血清脑丸增加阿尔茨海默病适应症临床试验通知书",
    "href": "http://stock.jrj.com.cn/2020/04/01104929166956.shtml",
    "datetime": "2020-04-01 10:49:00",
    "code": "600535"
  },
  {
    "title": "天士力养血清脑丸增加阿尔茨海默病（AD）适应症获得临试通知",
    "href": "http://stock.jrj.com.cn/2020/03/31184129159752.shtml",
    "datetime": "2020-03-31 18:41:29",
    "code": "600535"
  },
  {
    "title": "天士力：养血清脑丸增加阿尔茨海默病（AD）适应症获临床试验通知书",
    "href": "http://stock.jrj.com.cn/2020/03/31173129158866.shtml",
    "datetime": "2020-03-31 17:31:27",
    "code": "600535"
  },
  {
    "title": "天士力：公司获批进行研究生产中药配方颗粒",
    "href": "http://stock.jrj.com.cn/2020/03/26163429118636.shtml",
    "datetime": "2020-03-26 16:34:00",
    "code": "600535"
  },
  {
    "title": "天士力：获批进行研究生产中药配方颗粒",
    "href": "http://stock.jrj.com.cn/2020/03/26162929118586.shtml",
    "datetime": "2020-03-26 16:29:12",
    "code": "600535"
  },
  {
    "title": "天士力：获得天津药监局同意研究生产中药配方颗粒批复",
    "href": "http://stock.jrj.com.cn/2020/03/26160729118454.shtml",
    "datetime": "2020-03-26 16:07:50",
    "code": "600535"
  },
  {
    "title": "天士力：复工防疫两手抓 积极进行医疗援助",
    "href": "http://stock.jrj.com.cn/2020/03/11182029002341.shtml",
    "datetime": "2020-03-11 18:20:00",
    "code": "600535"
  },
  {
    "title": "良品铺子IPO：网上弃购12万股 网下天士力控股等17名投资者弃购",
    "href": "http://stock.jrj.com.cn/2020/02/17201028840933.shtml",
    "datetime": "2020-02-17 20:10:59",
    "code": "600535"
  },
  {
    "title": "天士力：藿香正气滴丸销售收入约占公司2018年度医药工业营收的1.91%",
    "href": "http://stock.jrj.com.cn/2020/02/05195828777914.shtml",
    "datetime": "2020-02-05 19:58:50",
    "code": "600535"
  },
  {
    "title": "天士力：藿香正气滴丸2018年度销售收入约占公司医药工业营收的1.91%",
    "href": "http://stock.jrj.com.cn/2020/02/05192928777780.shtml",
    "datetime": "2020-02-05 19:29:00",
    "code": "600535"
  },
  {
    "title": "天士力药品拟中标国家药品集中采购",
    "href": "http://stock.jrj.com.cn/2020/02/02211628749398.shtml",
    "datetime": "2020-02-02 21:16:08",
    "code": "600535"
  },
  {
    "title": "天士力：参股公司I-MAB在美国纳斯达克证券交易所挂牌上市",
    "href": "http://stock.jrj.com.cn/2020/01/20224128708464.shtml",
    "datetime": "2020-01-20 22:41:57",
    "code": "600535"
  },
  {
    "title": "天士力：参股公司I-MAB在纳斯达克挂牌上市",
    "href": "http://stock.jrj.com.cn/2020/01/20181728706971.shtml",
    "datetime": "2020-01-20 18:17:15",
    "code": "600535"
  },
  {
    "title": "天士力：参股公司在美国纳斯达克证券交易所挂牌上市",
    "href": "http://stock.jrj.com.cn/2020/01/20172928706756.shtml",
    "datetime": "2020-01-20 17:29:00",
    "code": "600535"
  },
  {
    "title": "天士力：公司药品拟中标国家药品集中采购",
    "href": "http://stock.jrj.com.cn/2020/01/19190328701839.shtml",
    "datetime": "2020-01-19 19:03:05",
    "code": "600535"
  },
  {
    "title": "天士力药品吲达帕胺片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/01/14214928677277.shtml",
    "datetime": "2020-01-14 21:49:58",
    "code": "600535"
  },
  {
    "title": "天士力芪苓温肾消囊颗粒获得临床试验通知",
    "href": "http://stock.jrj.com.cn/2020/01/13174028668129.shtml",
    "datetime": "2020-01-13 17:40:05",
    "code": "600535"
  },
  {
    "title": "天士力：芪苓温肾消囊颗粒获临床批准 累计研发投入1210.76万元",
    "href": "http://stock.jrj.com.cn/2020/01/13163928667767.shtml",
    "datetime": "2020-01-13 16:39:32",
    "code": "600535"
  },
  {
    "title": "天士力：芪苓温肾消囊颗粒获临床试验通知书",
    "href": "http://stock.jrj.com.cn/2020/01/13163028667922.shtml",
    "datetime": "2020-01-13 16:30:00",
    "code": "600535"
  },
  {
    "title": "天士力：芪参益气滴丸新增适应症获临床试验通知书 累计研发投入943.32万元",
    "href": "http://stock.jrj.com.cn/2020/01/09154028650150.shtml",
    "datetime": "2020-01-09 15:40:45",
    "code": "600535"
  },
  {
    "title": "天士力芪参益气滴丸新增适应症获临试通知",
    "href": "http://stock.jrj.com.cn/2020/01/07181128638073.shtml",
    "datetime": "2020-01-07 18:11:16",
    "code": "600535"
  },
  {
    "title": "天士力：芪参益气滴丸新增适应症获得临床试验通知书",
    "href": "http://stock.jrj.com.cn/2020/01/07160728637478.shtml",
    "datetime": "2020-01-07 16:07:15",
    "code": "600535"
  },
  {
    "title": "天士力子公司获得药品注册批件 项目累计研发总投入819.81万",
    "href": "http://stock.jrj.com.cn/2020/01/02222528619654.shtml",
    "datetime": "2020-01-02 22:25:31",
    "code": "600535"
  },
  {
    "title": "天士力：子公司他达拉非片获药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/01/02191528618984.shtml",
    "datetime": "2020-01-02 19:15:05",
    "code": "600535"
  },
  {
    "title": "天士力：他达拉非片获药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/01/02190928618979.shtml",
    "datetime": "2020-01-02 19:09:00",
    "code": "600535"
  },
  {
    "title": "天士力获他达拉非片药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/01/02183228618476.shtml",
    "datetime": "2020-01-02 18:32:34",
    "code": "600535"
  },
  {
    "title": "天士力芍麻止痉颗粒获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/12/26173628591193.shtml",
    "datetime": "2019-12-26 17:36:06",
    "code": "600535"
  },
  {
    "title": "天士力：芍麻止痉颗粒获药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/12/26172428591131.shtml",
    "datetime": "2019-12-26 17:24:21",
    "code": "600535"
  },
  {
    "title": "天士力：芍麻止痉颗粒获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/12/26162828590902.shtml",
    "datetime": "2019-12-26 16:28:00",
    "code": "600535"
  },
  {
    "title": "天士力出售营收贡献超50%子公司 “抱大腿”未必自救",
    "href": "http://stock.jrj.com.cn/2019/12/17085328544790.shtml",
    "datetime": "2019-12-17 08:53:00",
    "code": "600535"
  },
  {
    "title": "子公司拟收购天士营销与陕西天士力物流 重药控股加快推进全国性网络布局",
    "href": "http://stock.jrj.com.cn/invest/2019/12/17080328544528.shtml",
    "datetime": "2019-12-17 08:03:00",
    "code": "600535"
  },
  {
    "title": "重药控股拟收购天士力旗下医药商业及物流资产",
    "href": "http://stock.jrj.com.cn/2019/12/16212728542159.shtml",
    "datetime": "2019-12-16 21:27:41",
    "code": "600535"
  },
  {
    "title": "天士力：筹划向重庆医药出售所持天士营销87.47%股权",
    "href": "http://stock.jrj.com.cn/2019/12/16192528541734.shtml",
    "datetime": "2019-12-16 19:25:31",
    "code": "600535"
  },
  {
    "title": "天士力：筹划出售所持天士营销87.47%股权给重庆医药",
    "href": "http://stock.jrj.com.cn/2019/12/16191328541711.shtml",
    "datetime": "2019-12-16 19:13:00",
    "code": "600535"
  },
  {
    "title": "天士力筹划重大资产出售事项",
    "href": "http://stock.jrj.com.cn/2019/12/16190728541668.shtml",
    "datetime": "2019-12-16 19:07:02",
    "code": "600535"
  },
  {
    "title": "天士力股东质押4500万股 前三季度净利同比下滑17%",
    "href": "http://stock.jrj.com.cn/2019/12/02100428476317.shtml",
    "datetime": "2019-12-02 10:04:32",
    "code": "600535"
  },
  {
    "title": "猎鹰看盘：为什么说眼下是成长投资的天堂？",
    "href": "http://stock.jrj.com.cn/invest/2019/12/01221528473853.shtml",
    "datetime": "2019-12-01 22:15:47",
    "code": "600535"
  },
  {
    "title": "天士力：子公司产品纳入《国家医保目录》",
    "href": "http://stock.jrj.com.cn/2019/11/28163028463638.shtml",
    "datetime": "2019-11-28 16:30:55",
    "code": "600535"
  },
  {
    "title": "天士力：子公司产品新纳入国家医保目录",
    "href": "http://stock.jrj.com.cn/2019/11/28154928463412.shtml",
    "datetime": "2019-11-28 15:49:00",
    "code": "600535"
  },
  {
    "title": "天士力股东天士力控股集团质押1.11亿股 2019年上半年净利同比下滑3%",
    "href": "http://stock.jrj.com.cn/2019/11/23134028441289.shtml",
    "datetime": "2019-11-23 13:40:20",
    "code": "600535"
  },
  {
    "title": "天士力：2019年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/10/29001028313377.shtml",
    "datetime": "2019-10-29 00:10:05",
    "code": "600535"
  },
  {
    "title": "天士力前三季度盈利11.32亿 同比减少17.31%",
    "href": "http://stock.jrj.com.cn/2019/10/28183328311224.shtml",
    "datetime": "2019-10-28 18:33:15",
    "code": "600535"
  },
  {
    "title": "天士力：前三季净利11.32亿元 同比下降17%",
    "href": "http://stock.jrj.com.cn/2019/10/28155428310428.shtml",
    "datetime": "2019-10-28 15:54:35",
    "code": "600535"
  },
  {
    "title": "天士力前三季净利同比降17.31%",
    "href": "http://stock.jrj.com.cn/2019/10/28155228310413.shtml",
    "datetime": "2019-10-28 15:52:20",
    "code": "600535"
  },
  {
    "title": "天士力：前三季净利同比降17.31%",
    "href": "http://stock.jrj.com.cn/2019/10/28154728310405.shtml",
    "datetime": "2019-10-28 15:47:00",
    "code": "600535"
  },
  {
    "title": "天士力：右佐匹克隆片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2019/10/22210228284523.shtml",
    "datetime": "2019-10-22 21:02:53",
    "code": "600535"
  },
  {
    "title": "天士力：子公司药品通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2019/10/22164728283210.shtml",
    "datetime": "2019-10-22 16:47:00",
    "code": "600535"
  },
  {
    "title": "天士力旗下国台酒业有望于2020年4月申报IPO",
    "href": "http://stock.jrj.com.cn/2019/10/22125928282064.shtml",
    "datetime": "2019-10-22 12:59:00",
    "code": "600535"
  },
  {
    "title": "天士力：第七届董事会第11次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/10/16215028258008.shtml",
    "datetime": "2019-10-16 21:50:01",
    "code": "600535"
  },
  {
    "title": "天士力：第七届董事会第10次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/08/22000028013225.shtml",
    "datetime": "2019-08-22 00:00:11",
    "code": "600535"
  },
  {
    "title": "天士力：2019年半年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/08/22000028013224.shtml",
    "datetime": "2019-08-22 00:00:10",
    "code": "600535"
  },
  {
    "title": "天士力半年报营收同比增长11% 创新药转型战略兑现",
    "href": "http://stock.jrj.com.cn/2019/08/21170328011088.shtml",
    "datetime": "2019-08-21 17:03:00",
    "code": "600535"
  },
  {
    "title": "天士力2019年上半年主营业务收入93.78亿 蒂清销售增长",
    "href": "http://stock.jrj.com.cn/2019/08/21163428010908.shtml",
    "datetime": "2019-08-21 16:34:18",
    "code": "600535"
  },
  {
    "title": "天士力2019年上半年净利8.99亿 营业成本增长",
    "href": "http://stock.jrj.com.cn/2019/08/21160028010749.shtml",
    "datetime": "2019-08-21 16:00:30",
    "code": "600535"
  },
  {
    "title": "天士力：上半年净利8.99亿元 同比下降2.86%",
    "href": "http://stock.jrj.com.cn/2019/08/21154628010675.shtml",
    "datetime": "2019-08-21 15:46:20",
    "code": "600535"
  },
  {
    "title": "天士力：上半年净利同比下降2.86%",
    "href": "http://stock.jrj.com.cn/2019/08/21154228010671.shtml",
    "datetime": "2019-08-21 15:42:00",
    "code": "600535"
  },
  {
    "title": "天士力股东天士力控股集团解除质押5569万股",
    "href": "http://stock.jrj.com.cn/2019/08/04153427926579.shtml",
    "datetime": "2019-08-04 15:34:17",
    "code": "600535"
  },
  {
    "title": "天士力股东天士力控股集团质押7000万股 公司去年净利同比增长12%",
    "href": "http://stock.jrj.com.cn/2019/07/31074527906783.shtml",
    "datetime": "2019-07-31 07:45:45",
    "code": "600535"
  },
  {
    "title": "天士力股东天士力控股集团质押8900万股 公司去年净利增长12%",
    "href": "http://stock.jrj.com.cn/2019/06/30174827774219.shtml",
    "datetime": "2019-06-30 17:48:10",
    "code": "600535"
  },
  {
    "title": "天士力：2018年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2019/06/06093027670622.shtml",
    "datetime": "2019-06-06 09:30:11",
    "code": "600535"
  },
  {
    "title": "天士力股价快速跳水逼近跌停 创6年多新低",
    "href": "http://stock.jrj.com.cn/2019/06/05095627666341.shtml",
    "datetime": "2019-06-05 09:56:05",
    "code": "600535"
  },
  {
    "title": "天士力：子公司创新药获得临床试验通知书",
    "href": "http://stock.jrj.com.cn/2019/05/14174127569582.shtml",
    "datetime": "2019-05-14 17:41:07",
    "code": "600535"
  },
  {
    "title": "天士力：子公司获得药物临床试验通知书",
    "href": "http://stock.jrj.com.cn/2019/05/14153727569131.shtml",
    "datetime": "2019-05-14 15:37:19",
    "code": "600535"
  },
  {
    "title": "估值125亿 天士力生物分拆赴港上市",
    "href": "http://stock.jrj.com.cn/2019/04/30053427510410.shtml",
    "datetime": "2019-04-30 05:34:26",
    "code": "600535"
  },
  {
    "title": "天士力：证监会受理天士力生物港股上市申请",
    "href": "http://stock.jrj.com.cn/2019/04/25200527483580.shtml",
    "datetime": "2019-04-25 20:05:12",
    "code": "600535"
  },
  {
    "title": "天士力：证监会受理天士力生物港股上市申请",
    "href": "http://stock.jrj.com.cn/2019/04/25192427483364.shtml",
    "datetime": "2019-04-25 19:24:00",
    "code": "600535"
  },
  {
    "title": "天士力2019年第一季度营收增长16% 净利4.48亿元 董事长闫凯境未持有公司股份",
    "href": "http://stock.jrj.com.cn/2019/04/23084527463315.shtml",
    "datetime": "2019-04-23 08:45:57",
    "code": "600535"
  },
  {
    "title": "天士力：2019年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/04/23080027462673.shtml",
    "datetime": "2019-04-23 08:00:29",
    "code": "600535"
  },
  {
    "title": "天士力：2018年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/04/23080027462670.shtml",
    "datetime": "2019-04-23 08:00:29",
    "code": "600535"
  },
  {
    "title": "天士力：第七届董事会第8次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/04/23080027462671.shtml",
    "datetime": "2019-04-23 08:00:29",
    "code": "600535"
  },
  {
    "title": "天士力：关于召开2018年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2019/04/23080027462672.shtml",
    "datetime": "2019-04-23 08:00:29",
    "code": "600535"
  },
  {
    "title": "天士力去年净利15.45亿同比增12% 董事长闫凯境年薪727万元",
    "href": "http://stock.jrj.com.cn/2019/04/22220927457609.shtml",
    "datetime": "2019-04-22 22:09:41",
    "code": "600535"
  },
  {
    "title": "天士力：一季度净利同比增21% 北上资金小幅减持",
    "href": "http://stock.jrj.com.cn/2019/04/22163627454854.shtml",
    "datetime": "2019-04-22 16:36:00",
    "code": "600535"
  },
  {
    "title": "天士力：2018年净利同比增12% 拟10派3元",
    "href": "http://stock.jrj.com.cn/2019/04/22155827454460.shtml",
    "datetime": "2019-04-22 15:58:37",
    "code": "600535"
  },
  {
    "title": "关于核准天士力控股集团有限公司向合格投资者公开发行公司债券的批复",
    "href": "http://stock.jrj.com.cn/ipo/2019/04/22124027490693.shtml",
    "datetime": "2019-04-22 12:40:45",
    "code": "600535"
  },
  {
    "title": "天士力：抗肿瘤用药蒂清通过一致性评价",
    "href": "http://stock.jrj.com.cn/2019/03/20160627197343.shtml",
    "datetime": "2019-03-20 16:06:01",
    "code": "600535"
  },
  {
    "title": "天士力：抗肿瘤用药蒂清通过一致性评价 为国内首家",
    "href": "http://stock.jrj.com.cn/2019/03/20160227197348.shtml",
    "datetime": "2019-03-20 16:02:00",
    "code": "600535"
  },
  {
    "title": "引入战投天士力集团 迪安诊断发力数字经济",
    "href": "http://stock.jrj.com.cn/2019/02/22002027072916.shtml",
    "datetime": "2019-02-22 00:20:57",
    "code": "600535"
  },
  {
    "title": "迪安诊断定向减持引入天士力集团 合谋发展精准诊疗等三大领域",
    "href": "http://stock.jrj.com.cn/2019/02/12222727035768.shtml",
    "datetime": "2019-02-12 22:27:00",
    "code": "600535"
  },
  {
    "title": "迪安诊断：控股股东定向减持股份 引入战略投资者天士力集团",
    "href": "http://stock.jrj.com.cn/2019/02/12183127035139.shtml",
    "datetime": "2019-02-12 18:31:00",
    "code": "600535"
  },
  {
    "title": "[迪安诊断]迪安诊断与天士力集团达成战略合作,三大领域共谋发展机遇",
    "href": "http://stock.jrj.com.cn/2019/02/12000027055433.shtml",
    "datetime": "2019-02-12 00:00:00",
    "code": "600535"
  },
  {
    "title": "天士力：复方丹参滴丸获得军队特需药品批件",
    "href": "http://stock.jrj.com.cn/2018/12/25212926801951.shtml",
    "datetime": "2018-12-25 21:29:29",
    "code": "600535"
  },
  {
    "title": "天士力股东增持92万股 一致行动人持股比例合计为49.82%",
    "href": "http://stock.jrj.com.cn/2018/11/06131725310311.shtml",
    "datetime": "2018-11-06 13:17:00",
    "code": "600535"
  },
  {
    "title": "天士力：2018年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/10/30083025278013.shtml",
    "datetime": "2018-10-30 08:30:18",
    "code": "600535"
  },
  {
    "title": "天士力：81个品种纳入《国家基本药物目录》",
    "href": "http://stock.jrj.com.cn/hotstock/2018/10/29080025270506.shtml",
    "datetime": "2018-10-29 08:00:01",
    "code": "600535"
  },
  {
    "title": "天士力：已耗资逾6800万元回购股份",
    "href": "http://stock.jrj.com.cn/2018/10/28145425268714.shtml",
    "datetime": "2018-10-28 14:54:10",
    "code": "600535"
  },
  {
    "title": "天士力：已耗资逾6800万元回购股份",
    "href": "http://stock.jrj.com.cn/2018/10/28144725268709.shtml",
    "datetime": "2018-10-28 14:47:00",
    "code": "600535"
  },
  {
    "title": "天士力：81个品种纳入基药目录 3个产品首次入选",
    "href": "http://stock.jrj.com.cn/2018/10/26203125265864.shtml",
    "datetime": "2018-10-26 20:31:00",
    "code": "600535"
  },
  {
    "title": "天士力：已累计回购逾0.21%股份 耗资6816万元",
    "href": "http://stock.jrj.com.cn/hotstock/2018/10/08075925167996.shtml",
    "datetime": "2018-10-08 07:59:53",
    "code": "600535"
  },
  {
    "title": "天士力：已累计回购逾6800万元股份",
    "href": "http://stock.jrj.com.cn/2018/10/07151725163977.shtml",
    "datetime": "2018-10-07 15:17:55",
    "code": "600535"
  },
  {
    "title": "天士力：已累计回购逾6800万元股份",
    "href": "http://stock.jrj.com.cn/2018/10/07150025163967.shtml",
    "datetime": "2018-10-07 15:00:00",
    "code": "600535"
  },
  {
    "title": "天士力：首次回购82.57万股 耗资1775万元",
    "href": "http://stock.jrj.com.cn/hotstock/2018/09/19075925112474.shtml",
    "datetime": "2018-09-19 07:59:51",
    "code": "600535"
  },
  {
    "title": "天士力：首次回购股份1775万元",
    "href": "http://stock.jrj.com.cn/2018/09/18183525109094.shtml",
    "datetime": "2018-09-18 18:35:00",
    "code": "600535"
  },
  {
    "title": "天士力：止动颗粒纳入优先审评程序",
    "href": "http://stock.jrj.com.cn/hotstock/2018/09/13075925084893.shtml",
    "datetime": "2018-09-13 07:59:57",
    "code": "600535"
  },
  {
    "title": "天士力：公司产品止动颗粒纳入优先审评程序",
    "href": "http://stock.jrj.com.cn/2018/09/12160025082185.shtml",
    "datetime": "2018-09-12 16:00:00",
    "code": "600535"
  },
  {
    "title": "天士力：与Arbor就丹滴合作开发销售签署协议",
    "href": "http://stock.jrj.com.cn/2018/09/07143325063096.shtml",
    "datetime": "2018-09-07 14:33:00",
    "code": "600535"
  },
  {
    "title": "天士力：控股子公司与美国Arbor公司三方签署许可协议",
    "href": "http://stock.jrj.com.cn/2018/09/06180725058597.shtml",
    "datetime": "2018-09-06 18:07:55",
    "code": "600535"
  },
  {
    "title": "天士力：与美国ARBOR公司签署合作进行T89美国临床研发及美国销售许可协议",
    "href": "http://stock.jrj.com.cn/2018/09/06173525058433.shtml",
    "datetime": "2018-09-06 17:35:00",
    "code": "600535"
  },
  {
    "title": "天士力：2018年第三次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2018/09/04212025047025.shtml",
    "datetime": "2018-09-04 21:20:01",
    "code": "600535"
  },
  {
    "title": "天士力：拟斥资1亿-2亿元回购股份",
    "href": "http://stock.jrj.com.cn/hotstock/2018/08/20080024973366.shtml",
    "datetime": "2018-08-20 08:00:00",
    "code": "600535"
  },
  {
    "title": "天士力：半年报净利9.25亿元 同比增逾两成",
    "href": "http://stock.jrj.com.cn/hotstock/2018/08/20080024973348.shtml",
    "datetime": "2018-08-20 08:00:00",
    "code": "600535"
  },
  {
    "title": "天士力：2018年半年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/08/17224024968516.shtml",
    "datetime": "2018-08-17 22:40:08",
    "code": "600535"
  },
  {
    "title": "天士力：第七届董事会第5次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/08/17224024968515.shtml",
    "datetime": "2018-08-17 22:40:08",
    "code": "600535"
  },
  {
    "title": "天士力：关于召开2018年第三次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2018/08/17224024968517.shtml",
    "datetime": "2018-08-17 22:40:08",
    "code": "600535"
  },
  {
    "title": "天士力拟1亿-2亿元回购 半年报净利增逾两成",
    "href": "http://stock.jrj.com.cn/2018/08/17175524967637.shtml",
    "datetime": "2018-08-17 17:55:31",
    "code": "600535"
  },
  {
    "title": "天士力上半年净利同比增22% 拟1-2亿元回购股份",
    "href": "http://stock.jrj.com.cn/2018/08/17161624967139.shtml",
    "datetime": "2018-08-17 16:16:29",
    "code": "600535"
  },
  {
    "title": "天士力：上半年净利同比增22% 拟1-2亿元回购股份",
    "href": "http://stock.jrj.com.cn/2018/08/17161524967130.shtml",
    "datetime": "2018-08-17 16:15:00",
    "code": "600535"
  },
  {
    "title": "天士力：集团处方外流天津试点初获成功",
    "href": "http://stock.jrj.com.cn/2018/08/13140524944497.shtml",
    "datetime": "2018-08-13 14:05:00",
    "code": "600535"
  },
  {
    "title": "天士力：三黄睛视明丸获药物临床试验批件",
    "href": "http://stock.jrj.com.cn/2018/08/08211024926026.shtml",
    "datetime": "2018-08-08 21:10:00",
    "code": "600535"
  },
  {
    "title": "天士力三黄睛视明丸获得药物临床试验批件",
    "href": "http://stock.jrj.com.cn/2018/08/08202024925910.shtml",
    "datetime": "2018-08-08 20:20:42",
    "code": "600535"
  },
  {
    "title": "天士力：公司传统业务稳定 普佑克等产品快速成长",
    "href": "http://stock.jrj.com.cn/2018/07/20103824841765.shtml",
    "datetime": "2018-07-20 10:38:00",
    "code": "600535"
  },
  {
    "title": "中资药企海外布局加速：天士力拿下三款原研新药",
    "href": "http://stock.jrj.com.cn/2018/07/20003924840068.shtml",
    "datetime": "2018-07-20 00:39:07",
    "code": "600535"
  },
  {
    "title": "天士力：合作产品疗法先进 维持“买入”评级",
    "href": "http://stock.jrj.com.cn/2018/07/19101724836999.shtml",
    "datetime": "2018-07-19 10:17:00",
    "code": "600535"
  },
  {
    "title": "天士力：第七届董事会第4次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/07/17213024829906.shtml",
    "datetime": "2018-07-17 21:30:00",
    "code": "600535"
  },
  {
    "title": "天士力：估值重塑开启，老树新花逐步绽放",
    "href": "http://stock.jrj.com.cn/2018/07/12134224805385.shtml",
    "datetime": "2018-07-12 13:42:00",
    "code": "600535"
  },
  {
    "title": "天士力：生物药平台价值初显",
    "href": "http://stock.jrj.com.cn/2018/07/12092624804156.shtml",
    "datetime": "2018-07-12 09:26:00",
    "code": "600535"
  },
  {
    "title": "天士力：转型积极、模式领先的天士力",
    "href": "http://stock.jrj.com.cn/2018/06/29103424745555.shtml",
    "datetime": "2018-06-29 10:34:00",
    "code": "600535"
  },
  {
    "title": "天士力：PXT3003获药物临床试验批件",
    "href": "http://stock.jrj.com.cn/2018/06/14162624681533.shtml",
    "datetime": "2018-06-14 16:26:05",
    "code": "600535"
  },
  {
    "title": "天士力：PXT3003获得药物临床试验批件",
    "href": "http://stock.jrj.com.cn/2018/06/14162024681474.shtml",
    "datetime": "2018-06-14 16:20:00",
    "code": "600535"
  },
  {
    "title": "天士力从日本引进透析新药AJT240",
    "href": "http://stock.jrj.com.cn/2018/06/11162624664180.shtml",
    "datetime": "2018-06-11 16:26:53",
    "code": "600535"
  },
  {
    "title": "天士力：与日本EA制药签署协议 引进创新药物",
    "href": "http://stock.jrj.com.cn/2018/06/11160124664030.shtml",
    "datetime": "2018-06-11 16:01:32",
    "code": "600535"
  },
  {
    "title": "天士力：2017年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2018/05/28220024601598.shtml",
    "datetime": "2018-05-28 22:00:06",
    "code": "600535"
  },
  {
    "title": "天士力年报推10转4派4元 股权登记6月4日",
    "href": "http://stock.jrj.com.cn/2018/05/28175124600549.shtml",
    "datetime": "2018-05-28 17:51:28",
    "code": "600535"
  },
  {
    "title": "天士力：天士营销入选2018年新三板创新层挂牌公司名单",
    "href": "http://stock.jrj.com.cn/2018/05/28172524600436.shtml",
    "datetime": "2018-05-28 17:25:00",
    "code": "600535"
  },
  {
    "title": "[振东制药]振东制药、天士力等青年企业家赴甘肃考察",
    "href": "http://stock.jrj.com.cn/2018/05/25000024591023.shtml",
    "datetime": "2018-05-25 00:00:00",
    "code": "600535"
  },
  {
    "title": "天士力：第七届董事会第2次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/05/18234124561759.shtml",
    "datetime": "2018-05-18 23:41:51",
    "code": "600535"
  },
  {
    "title": "天士力拟设立二期员工持股计划",
    "href": "http://stock.jrj.com.cn/2018/05/18183624560697.shtml",
    "datetime": "2018-05-18 18:36:20",
    "code": "600535"
  },
  {
    "title": "白马股天士力隐忧：银行借款78亿 净利甩现金流很远",
    "href": "http://stock.jrj.com.cn/2018/05/14070824533225.shtml",
    "datetime": "2018-05-14 07:08:00",
    "code": "600535"
  },
  {
    "title": "天士力一季度净利3.72亿元 同比增16.77%",
    "href": "http://stock.jrj.com.cn/2018/04/17105224401086.shtml",
    "datetime": "2018-04-17 10:52:00",
    "code": "600535"
  },
  {
    "title": "天士力：2017年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2018/04/16231024397857.shtml",
    "datetime": "2018-04-16 23:10:03",
    "code": "600535"
  },
  {
    "title": "天士力：2018年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/04/16231024397856.shtml",
    "datetime": "2018-04-16 23:10:02",
    "code": "600535"
  },
  {
    "title": "天士力：第七届董事会第1次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/04/16231024397855.shtml",
    "datetime": "2018-04-16 23:10:02",
    "code": "600535"
  },
  {
    "title": "[东方航空]东航天津营业部赴天士力集团开展旅游集市活动",
    "href": "http://stock.jrj.com.cn/2018/04/13000024392187.shtml",
    "datetime": "2018-04-13 00:00:00",
    "code": "600535"
  },
  {
    "title": "天士力：引入美国礼来公司糖尿病创新药",
    "href": "http://stock.jrj.com.cn/2018/04/03213924347172.shtml",
    "datetime": "2018-04-03 21:39:00",
    "code": "600535"
  },
  {
    "title": "天士力：与美国礼来公司签署许可协议 引进创新药物",
    "href": "http://stock.jrj.com.cn/2018/04/03161524345575.shtml",
    "datetime": "2018-04-03 16:15:00",
    "code": "600535"
  },
  {
    "title": "天士力：薪火相传 再创辉煌",
    "href": "http://stock.jrj.com.cn/2018/03/28102324312869.shtml",
    "datetime": "2018-03-28 10:23:00",
    "code": "600535"
  },
  {
    "title": "天士力业绩重回高速增长轨道 净利润增长17%",
    "href": "http://stock.jrj.com.cn/2018/03/27141224306012.shtml",
    "datetime": "2018-03-27 14:12:00",
    "code": "600535"
  },
  {
    "title": "天士力：2017年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/03/26235024301653.shtml",
    "datetime": "2018-03-26 23:50:01",
    "code": "600535"
  },
  {
    "title": "天士力：第六届董事会第23次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/03/26235024301654.shtml",
    "datetime": "2018-03-26 23:50:01",
    "code": "600535"
  },
  {
    "title": "天士力：关于召开2017年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2018/03/26235024301655.shtml",
    "datetime": "2018-03-26 23:50:01",
    "code": "600535"
  },
  {
    "title": "天士力：2018年将分拆生物药板块赴港上市",
    "href": "http://stock.jrj.com.cn/2018/03/26221024301266.shtml",
    "datetime": "2018-03-26 22:10:00",
    "code": "600535"
  },
  {
    "title": "天士力：去年净利同比增17% 拟10转4派4元",
    "href": "http://stock.jrj.com.cn/2018/03/26193024300566.shtml",
    "datetime": "2018-03-26 19:30:00",
    "code": "600535"
  },
  {
    "title": "[天士力]闫希军的传承哲学:自我变革 全面国际化",
    "href": "http://stock.jrj.com.cn/2018/03/26000024305000.shtml",
    "datetime": "2018-03-26 00:00:00",
    "code": "600535"
  },
  {
    "title": "天士力：国产原创新药 溶栓领域王者",
    "href": "http://stock.jrj.com.cn/hotstock/2018/03/21085224270927.shtml",
    "datetime": "2018-03-21 08:52:23",
    "code": "600535"
  },
  {
    "title": "天士力厚积薄发 跨入发展新阶段",
    "href": "http://stock.jrj.com.cn/hotstock/2018/02/23055924137979.shtml",
    "datetime": "2018-02-23 05:59:54",
    "code": "600535"
  },
  {
    "title": "天士力：实控人一致行动人拟增持2000万元-6000万元",
    "href": "http://stock.jrj.com.cn/2018/02/12185024108684.shtml",
    "datetime": "2018-02-12 18:50:00",
    "code": "600535"
  },
  {
    "title": "天士力：降糖药产品线扩张 慢病研发梯队形成",
    "href": "http://stock.jrj.com.cn/hotstock/2017/12/07014823752975.shtml",
    "datetime": "2017-12-07 01:48:40",
    "code": "600535"
  }
]